Stock ScreenerStock IdeasTop Stocks To Sell NowStocks to Sell Today: Zen Rating of F As Of Friday, August 14, 2026F rated (Strong Sell) stocks have averaged an -12.86% annual decline going back to 2003. Even worse is how bad they do during corrections and bear markets. Own them at your own risk.
Stock ScreenerStock IdeasTop Stocks To Sell Now
Market Cap: $30M - $200B
Zen Rating: F
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GRCE | GRACE THERAPEUTICS INC | NASDAQ | Biotechnology | F | $33.69M | $2.07 | -1.43% | -$9.49M | -4.40x | 0.04 | Canada |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +28.50% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.